Your immune system ages — and that makes every flu season more dangerous
Older people don’t die from the flu more often simply because they’re frail. They die because their immune system can produce fewer new defenders each year while simultaneously staying locked in a…
A new review maps the landscape of immune aging with particular focus on respiratory infections like influenza. The researchers describe a paradox that immunogerontologists have studied for decades: as we age, the immune system becomes less effective at fighting actual threats while its overall inflammatory activity increases. The result is a system less capable of recognizing and neutralizing pathogens, yet constantly generating low-grade inflammatory responses in healthy tissue. This phenomenon has a name: inflammaging — a portmanteau of inflammation and aging.
The causes operate at several levels simultaneously. First, bone marrow produces fewer stem cells that develop into new immune cells as we get older. The thymus — a gland behind the breastbone that trains T-cells, the immune system’s specialized fighters — shrinks steadily after puberty and is functionally near-dormant by old age. This leaves a smaller, less diverse army of immune cells circulating in the bloodstream. Second, the cells that remain work less efficiently: mitochondria inside immune cells, the structures that generate energy, become damaged and sluggish. Third, senescent cells accumulate within the immune system itself — cells that have stopped dividing but continue secreting inflammatory signaling molecules into surrounding tissue.
Flu as a stress test for immune aging
Influenza is perhaps the clearest demonstration of how seriously immune aging plays out in practice. More than ninety percent of flu-related deaths in wealthy countries occur in people over 65. Vaccines demonstrably work less well in older adults: antibody production after a flu shot is weaker, and the immunological memory the vaccine is meant to establish fades faster. That’s not a failure of the vaccine — it’s a failure of the aging immune system to respond adequately.
The researchers also highlight a less-discussed but critical factor: the chronic low-grade inflammation that accompanies aging appears to amplify the severity of infections when they do take hold. This became starkly visible during Covid-19, when older patients were far more likely to develop a cytokine storm — an explosive inflammatory response in which the immune system damages healthy lung tissue in its intensity. That hyperreactivity doesn’t arise from nowhere; it builds on decades of accumulated inflammatory background noise.
What can be done — and what remains out of reach
The review surveys a range of interventions under investigation to slow or partially reverse immune aging. Senolytics — drugs that clear out senescent cells — show promising results in animal studies, but clinical trials in humans are still in early stages. Thymus regeneration, attempting to restore the shrunken gland’s function, is another active research front. There is also accumulating evidence that caloric restriction and time-restricted eating can slow the pace of immune aging, which places this article in an interesting dialogue with recent chrono-nutrition findings.
What the review doesn’t offer is a simple solution. Immune aging is not a single problem with a single cause. It is a system failing on multiple fronts simultaneously — and reversing it will likely require interventions targeting multiple fronts at once. Whether those interventions arrive before the demographic pressures of an aging population overwhelm healthcare systems during the next major respiratory outbreak is a question that remains unanswered.